Conference Coverage
Media
NewsNetwork
OncLive® TV
Peer Exchange
Insights
Podcasts
Attend An Event
State of the Science Summit
Regional Seminar Series
PER Conferences
Giants of Cancer Care
ISGIO
Webinars
OncLive Community

Register for a live broadcast to learn more about TRODELVY (sacituzumab govitecan-hziy) with Dr. Hope S. Rugo

SPECIALTY TOPICS
CURRENTLY VIEWING
All Specialties
Breast Cancer
Multiple Myeloma
Lung Cancer
Immuno-Oncology News
Gynecologic Oncology
Gastrointestinal Cancer
Colorectal Cancer
Ovarian Cancer
Prostate Cancer
Precision Medicine in Oncology®
Neoadjuvant HER2+
More >>
<< View all publications

Special Issues

Dr. Richardson on Preliminary Data With Belantamab Mafodotin in Multiple Myeloma
Dr. Richardson on Preliminary Data With Belantamab Mafodotin in Multiple Myeloma
Emerging MOAs in Multiple Myeloma: Updates From the 17th IMW   >   Videos
Addressing Belantamab Mafodotin-Related Corneal Events in Myeloma is Key to Continuing Treatment
Addressing Belantamab Mafodotin-Related Corneal Events in Myeloma is Key to Continuing Treatment
Emerging MOAs in Multiple Myeloma: Updates From the 17th IMW   >   Articles
"Fast and Furious" Development of Novel Approaches Changes Face of Myeloma Treatment
Emerging MOAs in Multiple Myeloma: Updates From the 17th IMW   >   Articles
BCMA-Targeting Strategies Transform Multiple Myeloma Treatment
BCMA-Targeting Strategies Transform Multiple Myeloma Treatment
Emerging MOAs in Multiple Myeloma: Updates From the 17th IMW   >   Articles
Dr. Popat on the DREAMM-1 Trial in Relapsed/Refractory Multiple Myeloma
Dr. Popat on the DREAMM-1 Trial in Relapsed/Refractory Multiple Myeloma
Emerging MOAs in Multiple Myeloma: Updates From the 17th IMW   >   Videos
Intriguing BCMA-Targeted Therapies Move Through Myeloma Pipeline
Intriguing BCMA-Targeted Therapies Move Through Myeloma Pipeline
Emerging MOAs in Multiple Myeloma: Updates From the 17th IMW   >   Articles
Myriad Modalities Advance Multiple Myeloma Paradigm
Myriad Modalities Advance Multiple Myeloma Paradigm
Emerging MOAs in Multiple Myeloma: Updates From the 17th IMW   >   Articles
Novel Therapies Surge Forward in Relapsed/Refractory Multiple Myeloma
Novel Therapies Surge Forward in Relapsed/Refractory Multiple Myeloma
Emerging MOAs in Multiple Myeloma: Updates From the 17th IMW   >   Articles
Expert Hails <em>NRG1</em> Fusions as the
Expert Hails NRG1 Fusions as the "Next Big Target" in Oncology
Developments in NRG1 Fusion+ Cancers   >   Articles
Dr. Avigan on BCMA-Targeted CAR T-Cell Therapy in Multiple Myeloma
Dr. Avigan on BCMA-Targeted CAR T-Cell Therapy in Multiple Myeloma
Emerging MOAs in Multiple Myeloma: Updates From the 17th IMW   >   Videos
Next Page >>
Publication Bottom Border
Border Publication
 
x